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Abstract
Introduction: Smoking is highly addictive, and nicotine abstinence is associated with withdrawal syndrome in 
hospitalized patients. In this study, we aimed to evaluate the impact of sudden nicotine abstinence on the 
development of agitation and delirium, and on morbidities and outcomes in critically ill patients who required 
respiratory support, either noninvasive ventilation or intubation, and mechanical ventilation.
Methods: We conducted a prospective, observational study in two intensive care units (ICUs). The 144 consecutive 
patients admitted to ICUs and requiring mechanical ventilation for >48 hours were included. Smoking status was 
assessed at ICU admission by using the Fagerström Test of Nicotine Dependence (FTND). Agitation, with the Sedation-
Agitation Scale (SAS), and delirium, with the Intensive Care Delirium Screening Checklist (ICDSC), were tested twice 
daily during the ICU stay. Agitation and delirium were defined by SAS >4 and ICDSC >4, respectively. Nosocomial 
complications and outcomes were evaluated.
Results: Smokers (n = 44) were younger and more frequently male and were more likely to have a history of alcoholism 
and to have septic shock as the reason for ICU admission than were nonsmokers. The incidence of agitation, but not 
delirium, increased significantly in the smoker group (64% versus 32%; P = 0.0005). Nicotine abstinence was associated 
with higher incidences of self-removal of tubes and catheters, and with more interventions, including the need for 
supplemental sedatives, analgesics, neuroleptics, and physical restraints. Sedation-free days, ventilator-free days, length 
of stay, and mortality in ICUs did not differ between groups. Multivariate analysis identified active smoking (OR, 3.13; 
95% CI, 1.45-6.74; P = 0.003) as an independent risk factor for agitation. Based on a subgroup of 56 patients, analysis of 
28 pairs of patients (smokers and nonsmokers in a 1:1 ratio) matched for age, gender, and alcoholism status found 
similar results regarding the role of nicotine withdrawal in increasing the risk of agitation during an ICU stay.
Conclusions: Nicotine withdrawal was associated with agitation and higher morbidities in critically ill patients. These 
results suggest the need to look specifically at those patients with tobacco dependency by using the FTND in ICU 
settings. Identifying patients at risk of behavioral disorders may lead to earlier interventions in routine clinical practice.
Introduction
Cigarette smoking is the main addiction in the world [1].
Tobacco use is associated with a high prevalence of alcohol
and drug dependence, depression, and anxiety disorders
[2,3]. Because the body develops a homeostatic response to
nicotine, smokers have withdrawal symptoms on absti-
nence from the drug [1]. These symptoms peak during the
first week of abstinence but sometimes are persistent for
several weeks or months, and then gradually decrease to
baseline levels [4,5]. In hospitalized patients, studies have
reported several manifestations related to sudden nicotine
abstinence, such as bradycardia, irritability, anxiety and agi-
tation, confusion, or hallucinations, but intensive care unit
(ICU) patients are usually excluded from published studies
[6].
Behavioral disorders such as delirium and agitation in the
critically ill occur with a high frequency, ranging from 15%
to 80% of patients, and have been associated with increased
morbidity and risk of mortality [7-13]. Many risk factors,
such as history of hypertension and alcoholism, higher
severity of acute disease, and clinical effects of sedative and
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analgesic agents, have been identified in the literature [12].
Few data exist in the literature regarding the behavioral
impact of sudden nicotine abstinence in the ICU setting,
except for one study, which identified smoking history as a
risk factor for delirium in critically ill patients [8]. More-
over, nicotine-replacement therapy (NRT) remains a con-
troversial topic in the ICU, and a retrospective study found
an association between NRT and mortality [14].
Thus, we aimed to evaluate the nicotine-withdrawal syn-
drome in critically ill patients. We hypothesized that depen-
dent smokers may have increased risk for agitation and
delirium, and then increased morbidity, such as infections
and accidental self-removal of tubes and catheters, related
to these behavioral disorders.
Materials and methods
Patients
This prospective observational study was conducted over a
period running from June 2007 to April 2008 in two adult
ICUs (a 22-bed medical ICU in the University Hospital of
Caen, Center 1, and an eight-bed medicosurgical ICU in the
tertiary Memorial Hospital of Saint-Lô, Center 2, Nor-
mandy, France). All patients admitted to the ICUs and
mechanically ventilated with either noninvasive ventilation
or intubation for respiratory support for longer than 48
hours were considered eligible for the investigation.
Patients were excluded if they were younger than 18 years
or were determined to have a history of chronic dementia
and psychosis, or acute neurologic diseases on admission,
such as severe traumatic brain injury, ischemic stroke, or
cerebral hemorrhage. NRT was forbidden during the study
period. The study was approved by the local ethics commit-
tee. Patients were included after informed consent of the
patient or next-of-kin was obtained.
Data collection
The following demographic and clinical data were collected
at ICU admission: age, gender, medical or surgical origin
referring to the primary admission diagnosis, history of
hypertension, chronic alcoholism and psychotropic therapy,
smoking status, and primary diagnosis on admission to the
ICUs. Alcohol consumption was considered chronic if it
persisted for the whole year before admission, as defined by
the National Institute on Alcohol Abuse and Alcoholism
criteria for unhealthy alcohol use in the United States
[15,16]. To assess the severity of the acute illness, the Sim-
plified Acute Physiology Score II (SAPS II) [17] and the
initial Sequential Organ Failure Assessment (SOFA) score
[18] were determined within 24 hours after ICU admission.
During the ICU stay, the duration of mechanical ventilation
(either invasive or noninvasive ventilation), the cumulative
dose and duration of drug exposure for sedation-analgesia,
and the number of days per patient with heavy sedation,
defined as a score ≥4 in the Ramsay sedation scale [19],
were recorded. Finally, ICU length of stay and mortality
were registered.
Definitions
Tabagism was evaluated according to the tobacco load,
which is quantified in pack-years, and the nicotine depen-
dence, as assessed by the Fagerström Test of Nicotine
dependence (FTND) [20] (Additional data file 1), obtained
from patients or their closest relatives. Patient dependency
was dichotomized in weak and strong by using a threshold
value of 4 in this smoking scale. Patients were divided into
two distinct groups: (1) smoker group, including patients
with active smoking status; and (2) nonsmoker group,
including patients with nonsmoking history or tobacco dis-
continuation for >6 months.
Agitation was assessed twice daily by nurses or physi-
cians until ICU discharge, by using the modified Sedation-
Agitation Scale (SAS) [21] (additional data file 2). SAS
lists three levels of agitation. Patients were classified as
"sedated" (SAS 1 to 3), "calm" (SAS 4), and "agitated"
(SAS 5 to 7). Similarly, delirium was assessed for each
patient twice daily by nurses or physicians until ICU dis-
charge by using the Intensive Care Delirium Screening
Checklist (ICDSC) score [22] (Additional data file 3). It
includes eight items based on the Diagnostic and Statistical
Manual of Mental Disorders (DSM) IV criteria [23] and fea-
tures delirium, including inattention, disorientation, halluci-
nation-delusion psychosis, psychomotor agitation or
retardation, inappropriate speech or mood, sleep/wake-
cycle disturbances, and symptom fluctuation. For each
abnormal item, a score of 1 was given. Patients with an
ICDSC score >4 were considered to be delirious. Sedated
patients with altered level of consciousness of A or B on the
ICDSC scale were not considered to have delirium. All
degrees of agitation and delirium were then confirmed by
an independent physician by using chart assessment.
Nosocomial infections were defined as follows: (1) venti-
lator-acquired pneumonia: clinical suspicion of pneumonia
(that is, clinical and radiographic criteria), and at least one
organism isolated by protective specimen brush at a con-
centration ≥103 colony-forming units (CFUs)/ml; (2) colo-
nization of central venous catheters: at least one organism
at a concentration ≥103 CFUs/ml identified by culture of the
catheter tip with the Brun-Buisson technique [24]; (3) uri-
nary catheter-related infection: the association of a leukocy-
turia at a concentration of ≥104/ml with the presence of an
organism at a concentration of 105 CFU/ml; (4) bacteremia:
a positive hemoculture with the isolation of an organism or
at least two positive hemocultures for a coagulase-negative
Staphylococcus, according to the usual definitions [25].
End points
Primary end points were either one or more agitation or
delirium events during the ICU stay. Secondary end pointsLucidarme et al. Critical Care 2010, 14:R58
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were ventilator-free days (days alive and free from mechan-
ical ventilation during the ICU stay); total dose of sedatives
and analgesics administered during the ICU stay, including
the extra doses needed to abort the episodes of agitation/
delirium; and sedation-free days (days alive and free from
sedatives and analgesics during the ICU stay); and compli-
cations related to agitation and delirium, such as require-
ment for supplemental sedation or physical restraints, use
of additional antipsychotic medication; and self-extubation,
self-removal of arterial, central venous and bladder cathe-
ters, nasogastric tubes, and nosocomial infections.
Statistical analysis
With a 30% baseline incidence of smokers in the general
population, we calculated that a sample size of at least 134
patients was necessary to achieve a 30% absolute difference
in agitation/delirium incidence among smokers and non-
smokers at a beta error of 0.2 and an alpha error of 0.05. For
univariate analysis, we used the χ2 test for categoric vari-
ables with continuity correction when appropriate, the
Fisher's Exact test for proportions, and the Mann-Whitney
test for quantitative variables. To determine the set of inde-
pendent predictors of agitation, a multivariate logistic
regression analysis was performed by using backward step-
wise selection. In the multivariate model, the outcome vari-
able studied was agitation, defined as success if agitation
occurred at least once. Variables with a P value < 0.1 in uni-
variate analysis were included in the regression analysis,
and then a P value of 0.2 was used to remove variables
from the model. To avoid analyses that might have resulted
in biased conclusions because of redundancy of the
included variables, SAPS II and SOFA scores were not
included in the same model. The performance of the final
model on the test set was assessed by using the c-index and
its 95% CI. To ensure that our findings were robust, we also
performed a case-control approach nested in our study to
assess the relative risk (RR) of agitation, according to the
smoking status. We matched each smoker with each non-
smoker in a 1:1 ratio. Each pair had to fulfill three condi-
tions: same age (± 5 years), same gender, and same status
regarding alcohol consumption (defined as presence or
absence of chronic alcoholism). We analyzed this subset of
patients by using the Wilcoxon test, the MacNemar χ2 test,
and the pair-matched Mantel-Haenszel adjusted RR. Analy-
sis was performed by using MedCalcSS version10.1 (Med-
Calc Software, Mariakerke, Belgium). The two-tailed
significance level was set at P < 0.05.
Results
Patients
In total, 916 admissions were screened for enrollment. One
hundred fifty consecutive patients met the inclusion crite-
ria. Six patients were secondarily excluded, leaving 144
patients for analysis (Figure 1). Forty-four patients were
classified as smokers, with a median FTND score of 5.
Among them, 18 (41%) patients had a score ≤4 in the
FTND scale and were considered to have weak dependency,
whereas 26 (59%) patients had an FTND value >4 and were
considered strongly dependent on nicotine. Each time it
was possible, the Fagerström test was obtained from the
patient at admission to the ICU or once recovery happened,
if the test was initially obtained from next-of-kin. Overall,
38 patients were able to respond to the FTND, 26 at admis-
sion to ICU, and 12 after recovery. Both patient and next-
of-kin responses were similar (median, 5.5 (4-7) versus 5
(4-7); P = 0.62, respectively), and in these cases, we have
recorded the patient's test responses for analysis. Thus, only
six (14%) FTND scores were obtained exclusively from
next-of-kin, and were recorded as well.
Mechanical ventilation
Regarding respiratory support, 45 (31%) patients in the
overall cohort received noninvasive ventilation. In this sub-
group of patients, the rate of intubation was 62% related to
failure of noninvasive ventilation. Thus, only 17 patients
(five smokers and 12 nonsmokers) were treated exclusively
with noninvasive ventilation. Based on SAS and ICDSC
scores, no statistical difference was recorded in the number
of agitation events between both groups (data not shown).
Figure 1 Flow chart of the patients admitted to the intensive care 
units (ICUs) during the study period. Center 1, Caen University Hos-
pital; Center 2: Memorial St-Lô Hospital.Lucidarme et al. Critical Care 2010, 14:R58
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Smoking, agitation, and outcome
Table 1 presents the baseline characteristics of patients.
Smokers were younger, and more of them were men, with
more history of alcoholism and septic shock at ICU admis-
sion than had nonsmokers. As shown in Table 2, the fre-
quency of agitation was higher in the smoker group (64%
versus 32%; P = 0.0005), but delirium was not affected by
smoking status. There was no central effect in the incidence
of agitation. In a subgroup analysis comparing weak and
strong tobacco dependencies according to FTND, no statis-
tical difference was observed for the development of agita-
tion (one or more episodes of agitation in nine patients
among 18 with FTND ≤4, and in 19 patients among 26 with
FTND >4, respectively; P = 0.2). Similarly, tobacco-load
distribution did not differ between smokers with and with-
out agitation during the ICU stay. In patients in whom agi-
tation developed, the median number of days with agitation
events was greater for smokers than for nonsmokers. The
rates of accidental removal of tubes and catheters were
higher for smokers, as well as the need for supplemental
sedative and analgesic medications, physical restraints, and
neuroleptics in comparison with nonsmokers (Table 2). The
neuroleptic of choice was haloperidol, which was mainly
instilled into the nasogastric tube. In five cases, patients
received droperidol by infusion because of contraindica-
tions for nasogastric tubes. For supplemental sedation,
propofol was the drug of choice, administered by conven-
tional titration dosing and followed by infusion. For
patients who were suspected to develop agitation/delirium
during benzodiazepine or opiate withdrawal, bolus dosing
and then higher doses of midazolam and morphine, respec-
tively, were administered by infusion. Altogether, no differ-
ences among groups of smokers and nonsmokers were
observed regarding type and dose of sedative medications
Table 1: Baseline characteristics of patients
Smokers
(n = 44)
Nonsmokers
 (n = 100)
P value
Age, yr 54 (45.5-62.5) 69 (58-78.5) <0.0001
Male gender, n (%) 40 (91) 70 (70) 0.006
Medical origin, n (%) 38 (86) 81 (81) 0.5
Source, admission from the ward, n (%) 9 (20) 29 (29) 0.3
Comorbidities, n (%)
Hypertension 7 (16) 20 (20) 0.6
Alcoholism 30 (68) 20 (20) <0.0001
Psychotropic drug use 15 (34) 25 (25) 0.3
Tobacco dependency
Pack-years 28 (22-40) NA
Fagerström score 5 (3-6) NA NA
Score ≤4 (Weak dependence), n (%) 20 (45)
Score >4 (Strong dependence), n (%) 24 (55)
Primary diagnosis, n (%)
Cardiac disease 1 (2) 16 (16)
Respiratory disease 15 (34) 41 (41)
Septic shock 14 (32) 18 (18) 0.007
Neurologic disease 6 (14) 7 (7)
Surgery 2 (4) 14 (14)
Other 6 (14) 8 (8)
SAPS II 46.5 (39-60) 50 (40.5-63) 0.3
SOFA score 7.5 (5.5-10) 8 (6-10) 0.5
Vasopressor, n (%) 28 (64) 51 (51) 0.2
Body temperature >38.5°C, n (%) 12 (27) 17 (17) 0.2
PaO2/FiO2 222 (165-257) 186 (135-250) 0.1
Abbreviations: NA, not attributable; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment. Data are 
presented as number (percentage) or median (interquartile range).Lucidarme et al. Critical Care 2010, 14:R58
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Table 2: Morbidity and mortality according to the smoking status
Smokers
(n = 44)
Nonsmokers
(n = 100)
P value
Evaluation of agitation (SAS ≥5)
Patients who develop at least one event, n (%) 28 (64) 32 (32) 0.0005
Days with agitation/patient 1.5 (0-4) 0 (0-1) 0.0006
Number of episodes of agitation/day/patient with 
agitation
2 (1-3.5) 2 (1-4) 0.9
Evaluation of delirium (ICDSC ≥4)
Patients who develop at least one event, n (%) 16 (37) 24 (24) 0.2
Rates of nosocomial infections$
Ventilator-associated pneumonia 16.7 15.9 0.5
Urinary tract infection 3.9 2.9 0.4
Catheter colonization 29.0 26.4 0.1
Bacteremia 4.1 3.9 0.6
Rates of accidental removal of tubes and catheters*
Endotracheal tube (self-extubation) 7.5 3.7 <0.0001
Arterial, venous, or bladder catheter 20.1 11.9 <0.0001
Nasogastric tube 33.5 22.4 0.0003
Sedation/analgesia
Number of days/patient with Ramsay score ≥4 3 (2-5) 4 (2-5.5) 0.4
Sedation-free days, days 1.5 (0-4) 2 (0-4.5) 0.6
Total dose of midazolam (mg/kg)§ 3 (0-14) 3 (0-10) 0.6
Total dose of propofol (mg/kg)§ 42 (9-122) 18 (0-79) 0.1
Total dose of sufentanyl (μg/kg)§ 12 (2-25) 9 (4-22) 0.9
Sedation/physical restraints related to agitation/delirium, n 
(%)
Supplemental sedatives and analgesics 23 (52) 15 (15) <0.0001
Physical restraints 21 (48) 13 (13) <0.0001
Neuroleptics 11 (25) 7 (7) 0.005
Mechanical ventilation (n = 100%)
Noninvasive ventilation (NIV), n (%) 14 (32) 31 (31) 0.9
Failure of NIV requiring intubation, n (% of NIV) 9 (64) 12 (39) 0.2
Length of NIV, days 3 (2-7) 2 (1-3.5) 0.07
Length of mechanical ventilation, days 10 (4.5-18.5) 10 (5.5-19.5) 0.6
Mechanical ventilation-free days, days 1.5 (0.5-4) 2 (0-4) 0.7
ICU LOS, days 15 (6-22.5) 14 (8-27.5) 0.8
ICU mortality, n (%) 7 (16) 28 (28) 0.1
Abbreviations: SAS = Sedation-Agitation Scale; ICDSC = Intensive Care Delirium Screening Checklist; NIV = noninvasive ventilation; ICU = 
Intensive Care Unit; LOS = length of stay. Data are presented as number (percentage) or median (interquartile range) when appropriate. $ 
Rates of nosocomial infections according to the time at risk for infection (number of ventilator-associated pneumonias, catheter 
colonizations, and urinary tract infections per 1,000 ventilation-days, 1,000 catheter-days, and 1,000 bladder catheter-days, respectively). 
Number of events of bacteremia for 1,000 days if ICU stay. *Rates of accidental removal of endotracheal tubes (self-extubation), venous, 
arterial, and bladder catheters, nasogastric tubes, according to the time at risk for removal (number of tubes or catheters removed per 1,000 
days in place). §Total dose of sedatives and analgesics administered during ICU stay, taking into account the extra doses needed to abort the 
episodes of agitation/delirium.Lucidarme et al. Critical Care 2010, 14:R58
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in the treatment of the agitation and delirium events. Over-
all, the rate of nosocomial infections, the use and doses of
sedatives and analgesics, sedation-free days and ventilator-
free days, lengths of stay in ICU, and mortality rates did not
differ among groups (Table 2).
Risk factors for agitation
By univariate analysis, the risk factors associated with agi-
tation were age, male gender, SOFA score, and active
smoking (Table 3). After adjustment for age, male gender,
chronic alcoholism, SAPS II, and PaO2/FiO2 ratio, multi-
variate analysis identified active smoking as an independent
predictor of agitation (OR, 3.13; 95% CI, 1.45 to 6.74)
(Table 3). The discriminatory performance of the composite
logistic model demonstrated a good c-index of 0.701 (95%
CI, 0.624 to 0.779) for agitation. Of note, of the 44 smok-
ers, 30 had a history of chronic alcoholism (P < 0.0001, χ2
test; Table 1). Chronic alcoholism, however, reached a level
of borderline significance for agitation only with univariate
analysis (OR, 1.91; 95% CI, 0.95 to 3.83; P = 0.07), and
then was not identified as independent predictor for agita-
tion in the multivariate analysis.
Matching was possible in 62 patients representing 43% of
the patients considered in the main analysis (Table 4). By
matching analysis, the rate of agitation increased from 42%
in matched controls to 80% among cases. A total of 10 and
three pairs of patients yielded the presence and absence of
agitation, respectively. Fifteen and three pairs of patients
were associated with the presence of agitation in smokers
and nonsmokers, respectively. The number of conflicting
pairs was statistically significant (χ2 = 8.2; P = 0.004), and
tobacco dependency was associated with an increased risk
for agitation compared with a no-smoking history (RR, 1.9;
95% CI, 1.3 to 3.0; P = 0.004).
Discussion
This prospective observational study is one of the first to
focus specifically on the impact of sudden nicotine absti-
nence in the ICU setting. Nicotine withdrawal was associ-
ated with agitation, but not with delirium, and smokers had
a greater frequency of adverse events, such as accidental
self-removal of tubes and catheters, and new interventions
including supplemental sedation and physical restraint
related to agitation events.
Incidence
As to external validity, the 31% of smokers we observed in
our cohort study, among them a majority of male gender,
reflects the proportion of smokers that are usually reported
in the general population [1]. Moreover, the 42% incidence
of agitation in this study is in agreement with those previ-
ously reported in critically ill patients [13,26-28]. Among
these publications that focused on agitation in the ICU set-
ting, only one included smoking status as a variable of
interest [13], which was, however, not identified as a risk
factor for agitation. This discrepancy may reflect differ-
ences in study design, case-mix population (for example,
medicosurgical patients versus medical patients), screening
Table 3: Univariate and multivariate analysis of factors associated with agitation in the ICU
Univariate analysis Multivariate analysis
Odd ratio (95%CI) P value Odd ratio (95%CI) P value
Age* 0.97 (0.95-0.99) 0.02 - -
Male gender 2.91 (1.21-6.99) 0.02 2.27 (0.90-5.68) 0.08
Hypertension 1.25 (0.88-1.60) 0.3
Chronic alcoholism* 1.91 (0.95-3.83) 0.07 - -
Chronic use of 
psychotropics
1.39 (0.67-2.90) 0.4
Septic shock 0.96 (0.64-1.45) 0.9
SAPS II 0.98 (0.96-1.01) 0.07 0.98 (0.96-1.01) 0.1
SOFA§ 0.88 (0.79-0.98) 0.02
Body temperature 
>38.5°C
1.22 (0.82-1.57) 0.2
PaO2/FiO2 0.81 (0.56-1.04) 0.09 - -
Active smoking 3.72 (1.77-7.83) 0.0005 3.13 (1.45-6.74) 0.003
Abbreviations: 95%CI = 95% confidence interval; SAPS II = Simplified Acute Physiology Score II; SOFA = Sequential Organ Failure Assessment. 
*Age and Chronic alcoholism were entered in the model and then removed from the model by the backward stepwise selection. §Despite 
statistical significance in univariate analysis, SOFA was not included in the multivariate model to avoid biased conclusions due to redundancy 
of the variables that are part of both SAPS II and SOFA.Lucidarme et al. Critical Care 2010, 14:R58
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Table 4: Characteristics of the 56 patients included in the matched case-control analysis
Smokers
 (n = 31)
Nonsmokers
(n = 31)
P Value
Age,$ years 56 (51-64) 58 (55-66) NA
Male gender,$ n (%) 30 (97) 30 (97) NA
Medical origin, n (%) 26 (84) 23 (74) 0.5
Source, admission from the 
ward, n (%)
6 (19) 8 (26) 0.8
Comorbidities, n (%)
Hypertension 5 (16) 8 (26) 0.5
Alcoholism 20 (65) 20 (65) NA
Psychotropic drug use 10 (32) 7 (23) 0.6
Tobacco dependency
Pack-years 31 (22-39) NA
Fagerström score 6 (3.5-6.5) NA
Score ≤4 (weak 
dependence), n (%)
13 (42)
Score >4 (strong 
dependence), n (%)
18 (64)
Primary diagnosis,$ n (%)
Cardiac disease 1 (4) 4 (13)
Respiratory disease 11 (35) 13 (42) 0.2
Septic shock 10 (32) 7 (23)
Neurologic disease 2 (6) 2 (6)
Surgery 1 (4) 4 (13)
Other 6 (19) 1 (4)
SAPS II 48 (38-59) 51 (40-61) 0.8
SOFA 8 (5-10) 8 (6-11) 0.4
Vasopressor, n (%) 23 (74) 20 (65) 0.6
Body temperature >38.5°C, n 
(%)
13 (42) 16 (52) 0.6
NIV, n (%) 10 (32) 9 (29) 0.9
Failure of NIV, n (% of NIV) 7 (70) 7 (78) 0.9
PaO2/FiO2 ratio 205 (165-260) 189 (146-255) 0.6
Sedation-analgesia
Number of days/
patient with Ramsay 
score ≥4
3 (2-5) 3 (2-6) 0.5
Sedation-free days, 
days
1 (0-4) 3 (0-6) 0.2
Total dose of 
midazolam (mg/kg)§
2 (0-11) 2 (0-8) 0.8
Total dose of 
propofol (mg/kg)§
48 (11-130) 7 (0-89) 0.3
Total dose of 
sufentanyl (μg/kg)§
13 (2-24) 10 (2-45) 0.7
At least one event of 
agitation,* n (%)
25 (80) 13 (42) 0.004Lucidarme et al. Critical Care 2010, 14:R58
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instrument (SAS versus Motor Activity Assessment Scale
[29]), and local sedation protocols.
Agitation
The presence of agitation in an acutely ill patient requiring
mechanical ventilation can be a potentially life-threatening
problem. Agitation has been associated with physiologic
changes producing interference with mechanical ventila-
tion, increased oxygen consumption, and failure to cooper-
ate with treatment [21]. In our study, smoking abstinence,
even in patients with weak tobacco dependency, was associ-
ated with agitation and then self-removal of catheters and
tubes, as already reported [13,26,28]. Nicotine withdrawal
as risk factor for agitation was also suggested by the results
that emerged from analyses nested in our trial. The risk of
agitation increased after adjustment for potential confound-
ers. The consistency of the results between the two statisti-
cal methods used for adjustment indicates their robustness
to assumptions and thus produces more confidence in their
validity.
The adequate strategy for dealing with agitation is not
clearly established in ICU. Patients with agitation were,
however, more likely to be given supplemental sedative and
analgesic agents or physical restraints to prevent self-
inflicted injuries and thus treatment interference [13,27,28].
Physical restraints could promote, however, the occurrence
of agitation, as described in psychiatric emergency depart-
ments [30]. The difficulty of supporting the use of this ther-
apeutic is also related to legal and ethical points of view.
Restraint is a complex topic and should be discontinued as
soon as the patient has no further indication for its use [31].
This may explain the increased prescription of antipsychot-
ics we observed in our smoker group, although no formal
protocol governed their use in both ICUs. In a retrospective
cohort study focusing on mechanically ventilated patients
[32], haloperidol use was associated with lower hospital
mortality, at least in part because of a reduced use of seda-
tives and analgesics. Haloperidol has, however, a number of
side effects, the most problematic of which is prolongation
of the corrected QT interval [33]. A large randomized trial
testing the best strategy to prevent and treat agitation is
warranted, and either nicotine-replacement therapy [34,35]
or drugs such as clonidine [36] and dexmedetomidine [37]
may be promising treatments in this situation.
Delirium
The 28% incidence of delirium we recorded at the low level
of the wide range cited in the literature (13% to 70%)
[8,11,38-40]. Heterogeneity between studies may also
reflect differences in patient selection, delirium scales, and
practices, including how sedation is administered, among
institutions. Nicotine withdrawal has been suggested as an
underrecognized cause of delirium in patients with acute
brain injury [41]. In contrast to the finding of Dubois and
colleagues [8], we found no association between nicotine
withdrawal and delirium. This discrepancy may, however,
be explained partly by the small size of our cohort, the
exclusion of acute neurologic diseases in our study, the
absence of a standardized protocol for sedation and antipsy-
chotic medications, and the difficulties of standardizing the
recording of the ICDSC items by both nurses and physi-
cians. As reported by others in trauma patients [39] and
mechanically ventilated medical patients [40], using
another tool (for example, CAM-ICU [9]) and categorizing
as either hypoactive or hyperactive delirium might have
elicited the delirium incidence and then found a possible
association between smoking and hyperactive delirium.
Limits of the study
Some study limitations must be addressed. First, objective
measurement of tobacco addiction, like urinary cotinine,
was not performed, and conclusions drawn from this obser-
vational study in a small number of patients cannot be gen-
eralized. The lack of any association between the level of
addiction and either agitation rate or most important out-
comes (length of stay, organ failure, and mortality) may
also be the result of the small sample size. Second, tobacco-
smoking status and end points were not collected in a
blinded manner by nurses and staff, and this point may be
considered a potential bias. Third, the use of sedative and
analgesic drugs, as well as discontinuation of physical
restraints, were left to the attending physician's judgment,
and thus, were likely to be somewhat random. As a conse-
quence, "organ failure" of the brain (delirium and agitation)
At least one event of delirium, 
n (%)
11 (35) 7 (23) 0.4
ICU LOS, days 13 (6-23) 15 (7-30) 0.9
ICU mortality, n (%) 5 (16) 8 (26) 0.5
Results are expressed as number (%) or median (interquartile range) when appropriate. $Matched variables. §Total dose of sedatives and 
analgesics administered during ICU stay, taking into account the extra doses needed to abort the episodes of agitation/delirium. 
Abbreviations: NA = not attributable; SAPS II = Simplified Acute Physiology Score II; SOFA = Sequential Organ Failure Assessment; NIV = 
noninvasive ventilation; ICU = intensive care unit; LOS = length of stay.
Table 4: Characteristics of the 56 patients included in the matched case-control analysis (Continued)Lucidarme et al. Critical Care 2010, 14:R58
http://ccforum.com/content/14/2/R58
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may have been over- or underestimated in some cases. And
fourth, adjusted analyses can potentially yield distorted
associations by selection or omission of variables that influ-
ence outcome. Regarding age, gender, alcoholism, and sep-
tic shock, a large imbalance between smokers and
nonsmokers was observed in our cohort study and may be
considered as potential bias. These confounding factors are,
however, taken into account in the matched analysis that
confirms our finding.
Conclusions
In mechanically ventilated patients, sudden nicotine absti-
nence was associated with severe agitation and its conse-
quences, such as self-removal of tubes and catheters. These
results suggest the need to be aware of nicotine-withdrawal
syndrome in critically ill patients, and then support the
necessity to improve strategies to prevent and treat agitation
earlier. Based on these findings, the use of nicotine-replace-
ment therapy should be tested by a well-designed, random-
ized controlled clinical trial in the ICU setting.
Key messages
• Agitation is a common event in critically ill patients.
• Nicotine withdrawal was identified as risk factor of
agitation, but not delirium, in multivariate and matched
case-control analyses adjusted for confounding factors.
• Agitation was associated with a higher adverse-event
rate, such as accidental self-removal of tubes and cathe-
ters, and new interventions including supplemental
sedation and physical restraint.
• These results suggest the need to be aware of nicotine-
withdrawal syndrome in critically ill patients, and then
to support the necessity to improve strategies to prevent
and treat agitation earlier.
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